In the present study, it was found that TMEM59L was elevated and reduced 5‐FU sensitivity in 5‐FU‐resistant CRC cell lines while silencing TMEM59L expression increased ROS levels along with enhanced DNA damage and 5‐FU sensitivity in primary or drug‐resistant CRC cells. This evidence concerns the gene TMEM59L and colorectal carcinoma.